This inventor holds 5 USPTO granted patents. Top assignees: Glaxo Wellcome Inc., Glaxo Group Limited. Active years: 2000-2010.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Tres Cantos, ES (2001)
- Madrid, ES (2000 - 2010)
Company Filing History:
Years Active: 2000-2010
Title: Innovations of Jesus Chicharro Gonzalo
Introduction
Jesus Chicharro Gonzalo is a notable inventor based in Madrid, Spain. He has made significant contributions to the field of pharmaceuticals, particularly in the development of heterocyclic compounds. With a total of 5 patents to his name, his work has implications for the treatment of parasitic infections.
Latest Patents
Among his latest patents, Jesus has developed heterocyclic compounds, specifically 4-pyridone derivatives of Formula I. These compounds are designed for use in chemotherapy against certain parasitic infections, including malaria. Another significant patent involves 3-Chloro-6-(hydroxymethyl)-2-methyl-5-[4-({4-[(trifluoromethyl)oxy]phenyl}oxy)phenyl]-4(1H)-pyridinone, which also addresses treatment for malaria through its pharmaceutically acceptable salts and formulations.
Career Highlights
Throughout his career, Jesus has worked with prominent companies in the pharmaceutical industry, including Glaxo Wellcome Inc. and Glaxo Group Limited. His experience in these organizations has allowed him to contribute to important advancements in drug development.
Collaborations
Some of his notable coworkers include Jose Maria Bueno Calderon and M Pilar Manzano Chinchon. Their collaborative efforts have furthered research and innovation in their respective fields.
Conclusion
Jesus Chicharro Gonzalo's work exemplifies the impact of innovation in pharmaceuticals, particularly in combating parasitic infections. His contributions continue to influence the development of effective treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

